The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects
Abstract
Decoctions prepared from the roots of Astragali Radix are known as "Huangqi" and are widely used in traditional Chinese medicine for treatment of viral and bacterial infections, inflammation, as well as cancer. Astragaloside IV (AS-IV), one of the major compounds from the aqueous extract of Astragalus membranaceus, is a cycloartane-type triterpene glycoside chemical. To date, many studies in cellular and animal models have demonstrated that AS-IV possesses potent protective effects in cardiovascular, lung, kidney and brain. Based on studies over the past several decades, this review systematically summarizes the pharmacological effects, pharmacokinetics and the toxicity of AS-IV. We analyze in detail the pharmacological effects of AS-IV on neuroprotection, liver protection, anti-cancer and anti-diabetes, attributable to its antioxidant, anti-inflammatory, anti-apoptotic properties, and the roles in enhancement of immunity, attenuation of the migration and invasion of cancer cells and improvement of chemosensitivity of chemotherapy drugs. In addition, the latest developments in the combination of AS-IV and other active ingredients of traditional Chinese medicine or chemical drugs are detailed. These pharmacological effects are associated with multiple signaling pathways, including the Raf-MEK-ERK pathway, EGFR-Nrf2 signaling pathway, Akt/PDE3B signaling pathway, AMPK signaling pathway, NF-κB signaling pathway, Nrf2 antioxidant signaling pathways, PI3K/Akt/mTOR signaling pathway, PKC-α-ERK1/2-NF-κB pathway, IL-11/STAT3 signaling pathway, Akt/GSK-3β/β-catenin pathway, JNK/c-Jun/AP-1 signaling pathway, PI3K/Akt/NF-κB pathway, miRNA-34a/LDHA pathway, Nox4/Smad2 pathway, JNK pathway and NF-kB/PPARγ pathway. This review will provide an overall understanding of the pharmacological functions of astragaloside IV on neuroprotection, liver protection, anti-cancer and anti-diabetes. In light of this, AS-IV will be a potent alternative therapeutic agent for treatment of the above mentioned diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Hanash, S. (2003) · Nature · doi:10.1038/nature01514 · Cited by 900
Research review on the pharmacological effects of astragaloside IV
Li, L., Hou, X., Xu, R., Liu, C., & Tu, M. (2017) · Fundamental & Clinical Pharmacology · doi:10.1111/fcp.12232 · Cited by 330
Diagnosis and Management of High Risk Group for Gastric Cancer
Yoon, H., & Kim, N. (2015) · Gut and Liver · doi:10.5009/gnl14118 · Cited by 262
Pharmacological effects of Astragaloside IV: a literature review
Ren, S., Zhang, H., Mu, Y., Sun, M., & Liu, P. (2013) · Journal of Traditional Chinese Medicine · doi:10.1016/s0254-6272(13)60189-2 · Cited by 260
Gui, D., Guo, Y., Wang, F., Liu, W., Chen, J., Chen, Y., Huang, J., & Wang, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039824 · Cited by 152
Gui, D., Huang, J., Guo, Y., Chen, J., Chen, Y., Xiao, W., Liu, X., & Wang, N. (2013) · Cytokine · doi:10.1016/j.cyto.2013.01.008 · Cited by 144
Anti-hepatitis B Virus Activities of Astragaloside IV Isolated from Radix Astragali
Wang, S., Li, J., Huang, H. Y., Gao, W. Y., Zhuang, C., Li, B., Zhou, P., & Kong, D. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.132 · Cited by 135
Chen, Y., Gui, D., Chen, J., He, D., Luo, Y., & Wang, N. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000362974 · Cited by 125
Guo, H., Wang, Y., Zhang, X., Zang, Y., Zhang, Y., Wang, L., Wang, H., Wang, Y., Cao, A., & Peng, W. (2017) · Scientific Reports · doi:10.1038/s41598-017-07061-7 · Cited by 104
Cited by
Zeng, J., Bao, T., Yang, K., Zhu, X., Wang, S., Xiang, W., Ge, A., Zeng, L., & Ge, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1047550 · Cited by 175
Ashraf, M. V., Khan, S., Misri, S., Gaira, K. S., Rawat, S., Rawat, B., Khan, M. A. H., Shah, A. A., Asgher, M., & Ahmad, S. (2024) · Pharmaceuticals · doi:10.3390/ph17080975 · Cited by 102
Zhou, H., Ma, C., Wang, C., Gong, L., Zhang, Y., & Li, Y. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173976 · Cited by 73
Metadata
- Venue
- Advances in Pharmacology
- Publisher
- Elsevier
- Published
- 2020
- Volume
- 87
- Pages
- 89-112
- ISSN
- 1054-3589 (ISSN-L)
- OpenAlex
- W2995653856
- Cited by
- 430
- References
- 63
- FWCI
- 33.93
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects. https://app.cochat.ai/papers/10.1016/bs.apha.2019.08.002
- The paper
- Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects. (2020). Advances in Pharmacology. https://doi.org/10.1016/bs.apha.2019.08.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.